journal article Open Access Jan 01, 2022

[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures

View at Publisher Save 10.1155/2022/9605439
Abstract
Breast cancer is a global cause for concern owing to its high incidence around the world. The alarming increase in breast cancer cases emphasizes the management of disease at multiple levels. The management should start from the beginning that includes stringent cancer screening or cancer registry to effective diagnostic and treatment strategies. Breast cancer is highly heterogeneous at morphology as well as molecular levels and needs different therapeutic regimens based on the molecular subtype. Breast cancer patients with respective subtype have different clinical outcome prognoses. Breast cancer heterogeneity emphasizes the advanced molecular testing that will help on‐time diagnosis and improved survival. Emerging fields such as liquid biopsy and artificial intelligence would help to under the complexity of breast cancer disease and decide the therapeutic regimen that helps in breast cancer management. In this review, we have discussed various risk factors and advanced technology available for breast cancer diagnosis to combat the worst breast cancer status and areas that need to be focused for the better management of breast cancer.
Topics

No keywords indexed for this article. Browse by subject →

References
224
[1]
RiggioA. I. VarleyK. E. andWelmA. L. The lingering mysteries of metastatic recurrence in breast cancer 2021 https://www.nature.com/articles/s41416-020-01161-4.
[2]
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram et al.

CA: A Cancer Journal for Clinicians 10.3322/caac.21492
[3]
Incidence and Mortality and Epidemiology of Breast Cancer in the World

Mahshid Ghoncheh, Zahra Pournamdar, Hamid Salehiniya

Asian Pacific Journal of Cancer Prevention 10.7314/apjcp.2016.17.s3.43
[10]
Anders C. "Understanding and treating triple-negative breast cancer" Oncology (Williston Park). (2008)
[11]
Hubalek M. "Biological subtypes of triple-negative breast cancer" Clinical Neprology (2017)
[14]
Steinerová K. "Rozvoj rezistentní GvHD u pa­cientky léčené nivolumabem pro relaps Hodgkinova lymfomu po alogenní nepříbuzenské transplantaci" Klinicka onkologie (2019)
[18]
da Costa Vieira R. A. "Breast cancer screening in developing countries" Clinic (2017)
[20]
Nounou M. I. "Breast cancer: conventional diagnosis and treatment modalities and recent patents and technologies supplementary issue: targeted therapies in breast cancer treatment" Breast cancer: basic and clinical research (2015)
[21]
Sharma G. N. "Various types and management of breast cancer: an overview" Journal of advanced pharmaceutical technology & research (2010)
[26]
Lüönd F. "Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression" British Journal of Cancer (2021)
[35]
Kumar S. "Convalescent plasma: an evidence-based old therapy to treat novel coronavirus patients" Biotechnology to Combat COVID-19 (2022)
[37]
Gandhi A. K. "Burden of preventable cancers in India" Time To Strike The Cancer Epidemic (2017)
[38]
Gold E. B. "The timing of the age at which natural menopause occurs" Obstetrics and Gynecology Clinics (2011)
[41]
The effect of marital status on breast cancer-related outcomes in women under 65: A SEER database analysis

Leslie Hinyard, Lorinette Saphire Wirth, Jennifer M. Clancy et al.

The Breast 10.1016/j.breast.2016.12.008
[48]
Khodarahmi M. "The association between different kinds of fat intake and breast cancer risk in women" International journal of preventive medicine (2014)

Showing 50 of 224 references

Cited By
413
Nutrients
Metrics
413
Citations
224
References
Details
Published
Jan 01, 2022
Vol/Issue
2022(1)
License
View
Funding
Taif University Award: 2020/114
Cite This Article
Dharambir Kashyap, Deeksha Pal, Riya Sharma, et al. (2022). [Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures. BioMed Research International, 2022(1). https://doi.org/10.1155/2022/9605439
Related

You May Also Like

Mechanisms of Nanoparticle-Induced Oxidative Stress and Toxicity

Amruta Manke, Liying Wang · 2013

1,359 citations

Proteobacteria: A Common Factor in Human Diseases

G. Rizzatti, L. R. Lopetuso · 2017

1,052 citations

Medication Adherence Measures: An Overview

Wai Yin Lam, Paula Fresco · 2015

829 citations